Avadel Pharmaceuticals (AVDL) Change in Acquisitions & Divestments (2016 - 2022)
Historic Change in Acquisitions & Divestments for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Q4 2022 value amounting to $24.0 million.
- Avadel Pharmaceuticals' Change in Acquisitions & Divestments rose 2950.05% to $24.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $83.8 million, marking a year-over-year decrease of 1799.58%. This contributed to the annual value of $327.8 million for FY2024, which is 7515.66% up from last year.
- Latest data reveals that Avadel Pharmaceuticals reported Change in Acquisitions & Divestments of $24.0 million as of Q4 2022, which was up 2950.05% from $3.4 million recorded in Q3 2022.
- Avadel Pharmaceuticals' 5-year Change in Acquisitions & Divestments high stood at $194.4 million for Q1 2018, and its period low was $928000.0 during Q2 2020.
- Over the past 5 years, Avadel Pharmaceuticals' median Change in Acquisitions & Divestments value was $18.0 million (recorded in 2021), while the average stood at $32.3 million.
- As far as peak fluctuations go, Avadel Pharmaceuticals' Change in Acquisitions & Divestments plummeted by 9464.76% in 2020, and later surged by 264536.64% in 2021.
- Over the past 5 years, Avadel Pharmaceuticals' Change in Acquisitions & Divestments (Quarter) stood at $51.5 million in 2018, then tumbled by 88.34% to $6.0 million in 2019, then rose by 3.41% to $6.2 million in 2020, then surged by 197.92% to $18.5 million in 2021, then grew by 29.5% to $24.0 million in 2022.
- Its Change in Acquisitions & Divestments was $24.0 million in Q4 2022, compared to $3.4 million in Q3 2022 and $12.2 million in Q2 2022.